Spur Therapeutics is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.
Spur Therapeutics has raised $50.0M in total funding. The most recent round was Undisclosed. The last funding was announced in June 2024.
Spur Therapeutics's investors include Syncona Partners LLP.
Spur Therapeutics is headquartered in Stevenage, United Kingdom.
Spur Therapeutics is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.
Spur Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spur Therapeutics — Funding & Investors." VCBacked, June 17, 2024, https://www.vcbacked.co/company/spur-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Spur Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/spur-therapeutics
{{cite web |title=Spur Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/spur-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated